Publication Cover
Canadian Journal of Pain
Revue canadienne de la douleur
Volume 4, 2020 - Issue 1
1,408
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A scoping review to identify and map the multidimensional domains of pain in adults with advanced liver disease

ORCID Icon, , , , & ORCID Icon
Pages 210-224 | Received 19 Feb 2020, Accepted 04 Jun 2020, Published online: 15 Sep 2020

References

  • Peng J, Hepgul N, Higginson IJ, Gao W. Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliat Med. 2019;33(1):24–36. doi:10.117/0269216318807051.
  • Hamilton JP, Goldberg E, Chopra S. Management of pain in patients with advance chronic liver disease or cirrhosis. Uptodate. 2019. https://www.uptodate.com/contents/management-of-pain-in-patients-with-advanced-chronic-liver-disease-or-cirrhosis.
  • Goldberg E, Chopra S. Cirrhosis in adults: overview of complications, general management, and prognosis. Uptodate. 2018. https://www.uptodate.com/contents/cirrhosis-in-adults-overview-of-complications-general-management-and-prognosis.
  • Rakoski M, Goyal P, Spencer-Safier M, Weissman J, Mohr G, Volk M. Pain management in patient with cirrhosis. Clin Liver Dis. 2018;11(6):135–40. doi:10.1002/cld.711.
  • Klinge M, Coppler T, Liebschutz JM, Dugum M, Wassan A, DiMartini A, Rogal S. The assessment and management of pain in cirrhosis. Curr Hepato Rep. 2018;17(1):42–51. doi:10.1007/s11901-018-0389-7.
  • Lang CA, Conrad S, Garrett L, Battistutta D, Cooksley WG, Dunne WP, Macdonald GA. Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. J Pain Symptom Manag. 2006;31(4):335–44. doi:10.1016/j.jpainsymman.2005.08.016.
  • Coggins CC, Curtiss CP. Assessment and management of delirium: a focus on hepatic encephalopathy. Palliat Support Care. 2013;11(4):341–52. doi:10.1017/S1478951512000600.
  • Potosek J, Curry M, Buss M, Chittenden E. Integration of palliative care in end-stage liver disease and liver transplantation. J Palliat Med. 2014;17(11):1271–77. doi:10.1089/jpm.2013.0167.
  • Dueñas M, Ojeda B, Salazar A, Mico JA, Falide I. A review of chronic pain impacts on patients, their social environment and the health care system. J Pain Res. 2016;9:457–67. doi:10.2147/JPR.S105892.
  • Kelly EM, James PD, Murthy S, Antonova L, Wong F, Shaw-Stiffel T, Chalifoux M, Salim M, Tanuseputro P. Health care utilization and costs for patients with end-stage liver disease are significantly higher at the end of life compared to those of other decedents. Clin. Gastroenterol. Hepatol. Forthcoming:1–9. doi:10.1016/j.cgh.2019.01.046.
  • Canadian Liver Foundation. Clinical practice guidelines. 2017. https://www.liver.ca/professionals/health-professionals/#clinical-practice-guidelines.
  • American Association for the Study of Liver Diseases. Pract Guidelines. 2019. https://www.aasld.org/publications/practice-guidelines-0.
  • Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69(4):896–904. doi:10.1016/j.jhep.2018.05.036.
  • Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267–84. doi:10.1016/j.cell.2009.09.028.
  • Ahles TC. Cancer pain: research from multidimensional and illness representation models. Motiv Emot. 1993;17(3):225–43. doi:10.1007/BF00992221.
  • McGuire DB. Comprehensive and multidimensional assessment and measurement of pain. J Pain Symptom Manage. 1992;7(5):312–19. doi:10.1016/0885-3924(92)90064-O.
  • Melzack R, Katz J. Pain. Wiley Interdiscip Rev Cogn Sci. 2013;4(1):1–15. doi:10.1002/wcs.1201.
  • Mogil JS. Social modulation of and by pain in humans and rodents. Pain. 2015;156(4 Supplemental 1):S35–S41. doi:10.1097/01.j.pain.0000460341.62094.77.
  • RLM VB, Vissera KCP, van der Sande R, Bronkhorst E, Lerou JGC, Steegers MAH. Moving beyond pain scores: multidimensional pain assessment is essential for adequate pain management after surgery. PLoS ONE. 2017;12(5):e0177345. doi:10.1371/journal.pone.0177345.
  • Michalski D, Liebig S, Thomae E, Hinz A, Then Bergh F. Pain in patients with multiple sclerosis: a complex assessment including quantitative and qualitative measurements provides for a disease-related biopsychosocial pain model. J Pain Res. 2011;4:219–25. doi:10.2147/JPR.S20309.
  • Sweeney L, Moss-Morris R, Czuber-Dochan W, Murrells T, Norton C. Developing a better biopsychosocial understanding of pain in inflammatory bowel disease: a cross-sectional study. Eur J Gastroen Hepat 2020. 2019;32:335–44. doi:10.1097/MEG.0000000000001615.
  • Turk DC, Gatchel RJ. Psychological approaches to pain management: a practitioner’s handbooks. 2nd ed. New York, United States of America: The Guildford Press; 2002.
  • International Association for the Study of Pain. IASP’s proposed new definition of pain released for comment. 2019. https://www.iasp-pain.org/PublicationsNews/NewsDetail.aspx?ItemNumber=9218.
  • International Association for the Study of Pain. IASP terminology: pain. 2018. https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698.
  • Lynch M, Craig KD, Peng PWH. The challenge of pain: a multidimensional phenomenon. In: Lynch ME, Craig KD, Peng PWH, editors. Clinical pain management: a practical guide. West Sussex (UK): Blackwell Publishing Ltd; 2011. p. 1–5.
  • Treede R-D. The International association for the study of pain definition of pain: as valid in 2018 as in 1979, but in need of regularly updated footnotes. Pain Rep. 2018;3:e643. doi:10.1097/PR9.0000000000000643.
  • Gatchel RJ, McGeary DD, McGeary CA, Lippe B. Interdisciplinary chronic pain management: past, present, and future. Am Psychol. 2014;69(2):119–30. doi:10.1037/a0035514.
  • Day MA, Ehde DM, Ward LC, Hartoonian N, Alschuler KN, Turner AP, Kraft GH, Jensen MP. An empirical investigation of a biopsychosocial model of pain in multiple sclerosis. Clin J Pain. 2016;32(2):155–63. doi:10.1097/AJP.0000000000000240.
  • Gordon DB, Watt-Watson J, Hogans BB. Interprofessional pain education – with, from, and about competent, collaborative practice teams to transform pain care. Pain Rep. 2018;3(3):e663. doi:10.1097/PR9.0000000000000663.
  • Clarke H, Woodhouse LJ, Kennedy D, Stratford P, Katz J. Strategies aimed at preventing chronic post-surgical pain: comprehensive perioperative pain management after total joint replacement surgery. Physiother Can. 2011;63(3):289–304. doi:10.3138/ptc.2009-49P.
  • Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. doi:10.1080/13645570320000119616.
  • Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(69):1–9. doi:10.1186/1748-5908-5-69.
  • Colquhoun HL, Levac D, O’Brien KK, Straus S, Tricco AC, Perrier L, Kastner M, Moher D. Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol. 2014;67(12):1291–94. doi:10.1016/j.jclinepi.2014.03.013.
  • Tricco AC, Lillie E, Zarin W, O’Brien K, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73. doi:10.7326/M18-0850.
  • Gorospe F, Istanboulian L, Puts M, Wong D, Lee E, Dale C. Protocol for a scoping review study to identify and map biopsychosocial factors associated with pain in adults with advanced liver disease. BMJ Open. 2019;9:e033064. doi:10.1136/bmjopen-2019-033064.
  • Canadian Agency for Drugs and Technologies in Health. Grey matters: a practical tool for searching health-related grey literature. [ accessed 2019 Aug 15]. https://www.cadth.ca/resources/finding-evidence/grey-matters.
  • Aromataris E, Munn Z, editors. Joanna Briggs institute reviewer’s manual. The Joanna Briggs Institute. [accessed 2020 Feb 15]. https://reviewersmanual.joannabriggs.org/.
  • Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in endnote. J Med Libr Assoc. 2016;104(3):240–42. doi:10.3163/1536-5050.104.3.014.
  • Perrot S, Cohen M, Barke A, Korwisi B, Rief W, Treede R. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain. 2019;160(1):77–82. doi:10.1097/j.pain.0000000000001389.
  • Aziz Q, Giamberadino MA, Barke A, Korwisi B, Baranowski AP, Wesselmann U, Rief W, Treede R. The IASP classification of chronic pain for ICD-11: chronic secondary visceral pain. Pain. 2019;160(1):69–76. doi:10.1097/j.pain.0000000000001362.
  • Benoliel R, Svensson P, Evers S, Wang S, Barke A, Korwisi B, Rief W, Treede R. The IASP classification of chronic pain for ICD-11: chronic secondary headache or orofacial pain. Pain. 2019;160(1):60–68. doi:10.1097/j.pain.0000000000001435.
  • International Association for the Study of Pain. IASP terminology: paresthesia. 2018. https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698.
  • Hong QN, Pluye P, Fàbreguesb S, Bartletta G, Boardmanc F, Cargod M, et al. Mixed methods appraisal tool (MMAT) version 2018 user guide. Registration of Copyright (#1148552), Canadian Intellectual Property Office, Industry Canada. 2018. http://mixedmethodsappraisaltoolpublic.pbworks.com/w/file/fetch/127916259/MMAT_2018_criteria-manual_2018-08-01_ENG.pdf.
  • Ngamkham S, Vincent C, Finnegan L, Holden JE, Wang ZJ, Wilkie DJ. The McGill Pain Questionnaire as a multidimensional measure in people with cancer: an integrative review. Pain Manag Nurs. 2012;13(1):27–52. doi:10.1016/j.pmn.2010.12.003.
  • Abd El-Wahab EW. Health‑related quality of life among chronic HCV patients: measuring disease and treatment response impact. Ann Trop Med Public Health. 2016;9(3):152–58. doi:10.4103/1755-6783.181656.
  • Elfert AA, Ali LA, Soliman S, Zakaria S, Shehab El-Din S, Elkhalawany W, Abd-Elsalam S. Randomized controlled trial of baclofen in treatment of muscle cramps in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2016;28(11):1280–84. doi:10.1097/MEG.0000000000000714.
  • Abd-Elsalam S, Arafa M, Elkadeem M, Elfert A, Soliman S, Elkhalawany W, Badawi R. Randomized-controlled trial of methocarbamol as a novel treatment for muscle cramps in cirrhotic patients. Eur J Gastroenterol Hepatol. 2018;31(4):499–503. doi:10.1097/MEG.0000000000001310.
  • Abd-Elsalam S, El-Kalla F, Ali LA, Mosaad S, Alkhalawany W, Elemary B, Badawi R, Elzeftawy A, Hanafy A, Elfert A. Pilot study of orphenadrine as a novel treatment for muscle cramps in patients with liver cirrhosis. United European Gastroenterol J T. 2017;6(3):422–27. doi:10.1177/2050640617731261.
  • Abdi F, Daryani NE, Khorvash F, Yousefi Z. Experiences in individuals with liver cirrhosis. Gastroenterol Nurs. 2015;38(4):252–57. doi:10.1097/SGA.0000000000000122.
  • Acharya C, Betrapally NS, Gillevet PM, Sterling RK, Akbarali H, White MB, Ganapathy D, Fagan A, Sikaroodi M, Bajaj JS. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis. Aliment Pharmacol Ther. 2017;45(2):319–31. doi:10.1111/apt.13858.
  • Acharya SK, Balwinder S, Padhee AK, Nijhawan S, Tandon BN. Large volume paracentesis and intravenous dextran to treat tense ascites. J Clin Gastroenterol. 1992;14(1):31–35. doi:10.1097/00004836-199201000-00008.
  • Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, Marchesini G, Younossi ZM. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther. 2009;30(5):469–76. doi:10.1111/j.1365-2036.2009.04061.x.
  • Angeli P, Albino G, Carraro P, Pria MD, Merkel C, Caregaro L, De Bei E, Bortoluzzi A, Plebani M, Gatta A. Cirrhosis and muscle cramps: evidence of a causal relationship. Hepatology. 1996;23(2):264–73. doi:10.1002/hep.510230211.
  • Barboza KC, Salinas LM, Sahebjam F, Jesudian AB, Weisberg IL, Sigal SH. Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients. Metab Brain Dis. 2016;31(4):869–80. doi:10.1007/s11011-016-9817-y.
  • Baskol M, Ozbakir O, Coskun R, Baskol G, Saraymen R, Yucesoy M. The role of serum zinc and other factors on the prevalence of muscle cramps in non-alcoholic cirrhotic patients. J Clin Gatroenterol. 2004;38(6):524–29. doi:10.1097/01.mcg.0000129059.69524.d9.
  • Baumann AJ, Wheeler DS, James M, Turner R, Siegel A, Navarro VJ. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manage. 2015;50(6):882–86. doi:10.1016/j.jpainsymman.2015.07.014.
  • Bianchi G, Marchesini G, Nicolino F, Graziani R, Sgarbi D, Loguercio C, Abbiati R, Zoli M. Psychological status and depression in patients with liver cirrhosis. Digest Liver Dis. 2005;37(8):593–600. doi:10.1016/j.dld.2005.01.020.
  • Blackburn P, Freeston M, Baker CR, Jones DE, Newton JL. The role of psychological factors in the fatigue of primary biliary cirrhosis. Liver Int. 2007;27(5):654–61. doi:10.1111/j.1478-3231.2007.01500.x.
  • Blasiole JA, Shinkunas L, Labrecque DR, Arnold RM, Zickmund SL. Mental and physical symptoms associated with lower social support for patients with hepatitis C. World J Gastroenterol. 2006;12(29):4665–72. doi:10.3748/wjg.v12.i27.4665.
  • Bondini S, Kallman J, Dan A, Younoszai Z, Ramsey L, Nader F, Younossi ZM. Health-related quality of life in patients with chronic hepatitis B. Liver Int. 2007;27(8):1119–25. doi:10.1111/j.1478-3231.2007.01558.x.
  • Chatrath H, Liangpunsakul S, Ghabril M, Otte J, Chalasani N, Vuppalanchi R. Prevalence and morbidity associated with muscle cramps in patients with cirrhosis. Am J Med. 2012;125(10):1019–25. doi:10.1016/j.amjmed.2012.03.012.
  • Dan AA, Kallman JB, Srivastava R, Younoszai Z, Kim A, Younossi ZM. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index. Liver Transpl. 2008;14(3):321–26. doi:10.1002/lt.21376.
  • Dan AA, Martin LM, Crone C, Ong JP, Farmer DW, Wise T, Robbins SC, Younossi ZM. Depression, anemia and health-related quality of life in chronic hepatitis C. J Hepatol. 2006;44(3):491–98. doi:10.1016/j.jhep.2005.11.046.
  • Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH. Fatigue in patients with chronic Hepatitis B living in North America: results from the Hepatitis B Research Network (HBRN). Dig Dis Sci. 2016;61(4):1186–96. doi:10.1007/s10620-015-4006-0.
  • Fontana RJ, Moyer CA, Sonnad S, Lok ASF, Sneed-Pee N, Walsh J, Klein S, Webster S. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol. 2001;96(1):170–78. doi:10.1111/j.1572-0241.2001.03473.x.
  • Fritz E, Hammer J. Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress. Eur J Gastroenterol Hepatol. 2009;21(4):370–75. doi:10.1097/MEG.0b013e328318ed19.
  • Gallegos-Orozco JF, Fuentes AP, Argueta JG, Pérez-Pruna C, Hinojosa-Becerril C, Sara Sixtos-Alonso M, Cruz-Castellanos S, Gutiérrez-Reyes G, Olivera-Martínez MA, Gutiérrez-Ruiz MC, et al. Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res. 2003;34(2):124129. doi:10.1016/S0188-4409(03)00003-1.
  • Gutteling JJ, de Man RA, Busschbach JJ, Darlington AS. Health-related quality of life and psychological correlates in patients listed for liver transplantation. Hepatol Int. 2007;1(4):437–43. doi:10.1007/s12072-007-9035-0.
  • Gutteling JJ, de Man RA, van der Plas SM, Schalm SW, Busschbach JJ, Darlington AS. Determinants of quality of life in chronic liver patients. Aliment Pharmacol Ther. 2006;23(11):1629–35. doi:10.1111/j.1365-2036.2006.02934.x.
  • Hansen L, Leo MC, Chang MF, Zucker BL, Sasaki A. Pain and self-care behaviors in adult patients with ESLD: a longitudinal description. Journal of Palliative Care. 2014;30(1):32–40. PMCID: PMC4377279.
  • Häuser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol. 2004;2(2):157–63. doi:10.1016/S1542-3565(03)00315-X. PMID: 15017621.
  • Kallman J, O’Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci. 2007;52(10):2531–39. doi:10.1007/s10620-006-9708-x.
  • Kaltsakas G, Antoniou E, Palamidas EF, Gennimata S, Paraskeva F, Smyrnis A, Koutsoukou A, Milic-Emili J, Koulouris NG. Dyspnea and respiratory muscle strength in end-stage liver disease. World J Hepatol. 2013;5(2):56–63. doi:10.4254/wjh.v5.i2.56.
  • Macdonald S, Jepsen P, Alrubaiy L, Watson H, Vilstrup H, Jalan R. Quality of life measures predict mortality in patients with cirrhosis and severe ascites. Aliment Pharmacol Ther. 2019;49(3):321–30. doi:10.1111/apt.15084.
  • Madan A, Barth KS, Balliet WE, Hernandez-Tejada MA, Borckardt JJ, Malcolm R, Willner I, Koch D, Reuben A. Chronic pain among liver transplant candidates. Prog Transplant. 2012;22(4):379–84. doi:10.7182/pit2012535. PMID: 23187056.
  • Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R; Italian Study Group for quality of life in cirrhosis. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120(1):170–78. doi:10.1053/gast.2001.21193.
  • Paglione HB, Oliveira PC, Mucci S, Roza BA, Schirmer J. Quality of life, religiosity, and anxiety and depressive symptoms in liver transplantation candidates. Rev Esc Enferm USP. 2019;53:e03459. doi:10.1590/S1980-220X2018010203459.
  • Pérez-San-Gregorio MA, Martín-Rodríguez A, Domínguez-Cabello E, Fernández-Jiménez E, Pérez-Bernal J. Biopsychosocial functioning in liver patients of alcoholic etiology as a function of self-perceived pain level. Transplant Proc. 2012;44(9):2612–15. doi:10.1016/j.transproceed.2012.09.055.
  • Poonja Z, Brisebois A, van Zanten SV, Tandon P, Meeberg G, Karvellas CJ. Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin. Gastroenterol. Hepatol. 2014;12(4):692–98. doi:10.1016/j.cgh.2013.08.027.
  • Randall HB, Alhamad T, Schnitzler MA, Zhang Z, Ford-Glanton S, Axelrod DA, Segev DL, Kasiske BL, Hess GP, Yuan H, et al. Survival implications of opioid use before and after liver transplantation. Liver Transpl. 2017;23(3):305–14. doi:10.1002/lt.24714.
  • Rodrigue JR, Nelson DR, Reed AI, Hanto DW, Curry M. Fatigue and sleep quality before and after liver transplantation. Prog Transplant. 2010;20(3):221–33. doi:10.1177/152692481002000305. PMID: 20929106.
  • Rogal SS, Winger D, Bielefeldt K, Szigethy E. Pain and opioid use in chronic liver disease. 2013. Dig Dis Sci. 2013;58(10):2976–85. doi:10.1007/s10620-013-2638-5.
  • Rogal SS, Beste LA, Youk A, Fine MJ, Ketterer B, Zhang H, Leipertz S, Chartier M, Good CB, Kraemer KL, et al. Characteristics of opioid prescriptions to veterans with cirrhosis. Clin. Gastroenterol. Hepatol. 2019;17(6):1165–74. doi:10.1016/j.cgh.2018.10.021.
  • Rogal SS, Bielefeldt K, Wasan AD, Lotrich FE, Zickmund S, Szigethy E, DiMartini AF. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13(5):1009–16. doi:10.1016/j.cgh.2014.10.029.
  • Rogal SS, Bielefeldt K, Wasan AD, Szigethy E, Lotrich F, DiMartini AF. Fibromyalgia symptoms and cirrhosis. Dig Dis Sci. 2015;60(5):1482–89. doi:10.1007/s10620-014-3453-3.
  • Rogal SS, Winger D, Bielefeldt K, Rollman BL, Szigethy E. Healthcare utilization in chronic liver disease: the importance of pain and prescription opioid use. Liver Int. 2013;33(10):1497–503. doi:10.1111/liv.12215.
  • Roth K, Lynn J, Zhong Z, Borum M, Dawson NV. Dying with end stage liver disease with cirrhosis: insights from SUPPORT. J Am Geriatr Soc. 2000;48(S1):S122–S130. doi:10.1111/j.1532-5415.2000.tb03121.x. PMID: 10809465.
  • Bellomo R, Warrillow SJ, Reade MC. Why we should be wary of single-center trials. Crit Care Med. 2009;37(12):3114–19. doi:10.1097/CCM.0b013a3181bc7bd5.
  • Kimbell B, Murray BA. What is the patient experience in advanced liver disease? A scoping review of the literature. BMJ Support Palliat Care. 2015;5(5):471–80. doi:10.1136/bmjspcare-2012-000435.
  • Tapper EB, Kanwal F, Asrani SK, Ho C, Oychinsky N, Poterucha J, Flores A, Smith JE, Ankoma-Sey V, Luxon B, et al. Patient-reported outcomes in cirrhosis: a scoping review of the literature. Hepatology. 2018;67(6):2375–83. doi:10.1002/hep.29756.
  • Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepat Mon. 2014;14(10):e23539. doi:10.5812/hepatmon.23539.
  • Jamison RN, Link CL, Marceau LD. Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study. Pain Med. 2009;10(6):1084–94. doi:10.1111/j.1526-4637.2009.00679.x.
  • Edlund MJ, Sullivan MD, Han X, Booth BM. Days with pain and substance use disorders: is there an association? Clin J Pain. 2013;29(8):689–95. doi:10.1097/AJP.0b013e318s70fa77.
  • Baumann AE. Stigmatization, social distance and exclusion because of mental illness: the individual with mental illness as a ‘stranger’. Int Rev Psychiatry. 2007;19(2):131–35. doi:10.1080/09540260701278739.
  • de Barros PAL, de Freitas RFCP, da Silva LFG, Oliveira AGRC, Dos Santos Calderon P. Effectiveness of counseling on chronic pain management in patients with temporomandibular disorders. J Oral Facial Pain Headache. 2019:12. doi:10.11607/ofph.2163.
  • Schulz KH, Kroenicke S, Ewers H, Schulz H, Younossi ZM. The factorial structure of the Chronic Liver Disease Questionnaire (CLDQ). Qual Life Res. 2008;17(4):575–84. doi:10.1007/s11136-008-9332-7.
  • Morasco BJ, Huckans M, Loftis JM, Woodhouse J, Seelye A, Turk DC, Hauser P. Predictors of pain intensity and pain functioning in patients with hepatitis C virus. Gen Hosp Psychiatry. 2010;32(4):413–18. doi:10.1016/j.genhosppsych.2010.03.010.
  • Songer D. sychotherapeutic approaches in treatment of pain. Psychiatry. 2005;2(5):19–24. PMID: 21152145.
  • Wallston KA, Wallston BS, DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) scales. Health Educ Monog. 1978;6(2):160–70. doi:10.1177/109019817800600107. PMID: 689890.
  • Helmer SM, Krämer A, Mikolajczyk RT. Health-related locus of control and health behaviour among university students in North Rhine Westphalia, Germany. BMC Res Notes. 2012;5:703. doi:10.1186/1756-0500-5-703.
  • Christensen AJ, Bryant Howren M, Hillis SL, Kaboli P, Carter BL, Cvengros JA, Wallston KA, Rosenthal GE. Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence. J Gen Intern Med. 2010;25(5):397–402. doi:10.1186/1756-0500-5-703.
  • Jaremka LM, Andridge RR, Fagundes CP, Alfano CM, Povoski SP, Lipari AM, Agnese DM, Arnold MW, Farrar WB, Yee LD, et al. Pain, depression, and fatigue: loneliness as a longitudinal risk factor. Health Psycho. 2015;33(9):948–57. doi:10.1037/a0034012.
  • Stefaniak TJ, Dziedziul J, Walerzak AM, Stadnyk M, Sheikh A, Proczko-Markuszewska M, Laski D, Zadrozny AJJ, Smietanska IA, Lachinski AJ. Pain intensity and perceived social support among patients with pancreatic tumors. J Pain Relief. 2012;5(1):1–4. doi:10.4172/2167-0846.1000110.
  • López-Martínez AE, Esteve-Zarazaga R, Ramírez-Maestre C. Perceived social support and coping responses are independent variables explaining pain adjustment among chronic pain patients. J Pain. 2008;9(4):373–79. doi:10.1016/j.jpain.2007.12.002.
  • Webster F, Rice K, Katz J, Bhattacharyya O, Dale C, Upshur R. An ethnography of chronic pain management in primary care: the social organization of physicians’ work in the midst of the opioid crisis. PLoS One. 2019;14(5):e0215148. doi:10.1371/journal.pone.0215148.
  • Hawkley LC, Cacioppo JT. Loneliness matters: a theoretical and empirical review of consequences and mechanisms. Ann Behav Med. 2010;40(2):1–14. doi:10.1007/s12160-010-9210-8.
  • Durand F, Valla D. Assessment of the prognosis of cirrhosis: child-Pugh versus MELD. J Hepatol. 2005;42(Suppl 1):S100–107. doi:10.1016/j.jhep.2004.11.015.
  • Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine (Baltimore). 2016;95(8):e2877. doi:10.1097/MD.0000000000002877.
  • Morley S, Williams A, Hussain S. Estimating the clinical effectiveness of cognitive behavioural therapy in the clinic: evaluation of a CBT informed pain management programme. Pain. 2008;137(3):670–80. doi:10.1016/j.pain.2008.02.025.
  • Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain. Arthritis Care Res (Hoboken). 2011;63(11):S240–S252. doi:10.1002/acr.20543.
  • McKillop JM, Nielson WR. Improving the usefulness of the multidimensional pain inventory. Pain Res Manage. 2011;16(4):239–44. doi:10.1155/2011/873424. PMID: 22059193.